UnknownNot Applicable

OcuStem Nutritional Supplement in Diabetic Patients With Mild to Moderate Non-proliferative Retinopathy

30 participantsStarted 2014-09

Plain-language summary

The purpose of this study is to determine whether supplementation with OcuStem, a nutritional supplement, will reduce the progression of mild to moderate diabetic retinopathy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Current regular use of insulin for the treatment of diabetes
✓. Current regular use of oral anti-hyperglycemia agents for the treatment of diabetes
✓. Documented diabetes by ADA and/or WHO criteria.
✓. Presence of microaneurysms or at least mild non-proliferative diabetic retinopathy (level 20 or higher) on clinical exam.
✓. No presence of center-involved diabetic macular edema (DME) as evidenced by OCT central subfield thickness \<250 microns(or spectral domain OCT equivalent).
✓. Visual acuity light perception or better.

What they're measuring

Change in Electronic-ETDRS (Early Treatment Diabetic Retinopathy Study) visual acuity testing

Timeframe: 0 months, 3 months, 6 months

Trial details

NCT IDNCT02353923

SponsorAidan Products LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2016-05

View on ClinicalTrials.gov More Diabetic Retinopathy trials